Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008189 · ClinicalTrials.gov registry record · Phase 3
6-Year Follow-up of a Prevention Program for Bereaved Families
A Phase 3 study, sponsored by Arizona State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 244
- Enrollment target
NCT01008189: Completed Phase 3 study, sponsored by Arizona State University.
NCT01008189 is a Phase 3 study that has completed, run by Arizona State University. The registered enrollment target is 244 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01008189, a Phase 3 study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 244 participants
- Enrollment target
Study Summary
Six-years following participation in the Family Bereavement Program (FBP) participants in the program as compared to a self-study control group will have lower levels of mental health problems, lower one-year prevalence of mental disorder that meets diagnostic criteria, lower use of substances, higher levels of competence at achieving developmentally appropriate tasks in academic achievement and social competence, and better self-esteem. The effects of the FBP will be moderated by baseline levels of mental health problems and gender. Bereaved caregivers who participated in the program will also show lower levels of mental health problems as compared with controls. Program effects will be mediated by theoretical mediators targeted by the program.
Interventions
- BEHAVIORAL Self- study comparison group
- BEHAVIORAL Family Bereavement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 1996-01 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
What the finished NCT01008189 record still lists
NCT01008189 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Self- study comparison group is the first listed.
NCT01008189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01008189 about?
NCT01008189 is a clinical study titled "6-Year Follow-up of a Prevention Program for Bereaved Families". Six-years following participation in the Family Bereavement Program (FBP) participants in the program as compared to a self-study control group will have lower levels of mental health problems, lower one-year prevalence of mental disorder that meets diagnostic criteria, lower use of substances, high...
What is the current status of trial NCT01008189?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 244 participants. The study started on 1996-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT01008189?
The interventions under investigation include: Self- study comparison group (BEHAVIORAL), Family Bereavement Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01008189?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01008189's enrollment target sits among peer trials
244 1269th of 2000 higher than 732 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia